Literature DB >> 5331188

Dapsone-resistant lepromatous leprosy in England.

A R Adams, M F Waters.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5331188      PMCID: PMC1944071          DOI: 10.1136/bmj.2.5518.872

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  6 in total

1.  SULPHONE RESISTANCE IN LEPROSY. AN EXPERIMENTAL AND CLINICAL STUDY.

Authors:  J H PETTIT; R J REES
Journal:  Lancet       Date:  1964-09-26       Impact factor: 79.321

2.  CHEMOTHERAPY OF LEPROSY CHIEFLY WITH SULFAMETHOXYPYRIDAZINE.

Authors:  T HIRAKO; H SAKURAI
Journal:  Lepr Rev       Date:  1963-10       Impact factor: 0.537

3.  Effect of several anti-leprosy drugs on multiplication of human leprosy bacilli in footpads of mice.

Authors:  C C SHEPARD; Y T CHANG
Journal:  Proc Soc Exp Biol Med       Date:  1962-03

4.  Changes in the morphology of Mycobacterium leprae in patients under treatment.

Authors:  M F WATERS; R J REES
Journal:  Int J Lepr       Date:  1962 Jul-Sep

5.  Therapeutic trials in leprosy using serial biopsies.

Authors:  D S RIDLEY
Journal:  Lepr Rev       Date:  1958-01       Impact factor: 0.537

6.  Recent bacteriologic, immunologic and pathologic studies on experimental human leprosy in the mouse foot pad.

Authors:  R J Rees
Journal:  Int J Lepr       Date:  1965 Jul-Sep
  6 in total
  3 in total

1.  [Experimental chemotherapy of leprosy].

Authors: 
Journal:  Bull World Health Organ       Date:  1976       Impact factor: 9.408

2.  Experimental chemotherapy in leprosy.

Authors: 
Journal:  Bull World Health Organ       Date:  1976       Impact factor: 9.408

Review 3.  New prospects for the study of leprosy in the laboratory.

Authors:  R J Rees
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.